Search Details

Word: bristols (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Even if the critics don't always appreciate her work, Robison "is a writer's writer," says Bobbie Bristol, Robison's editor at Knopf in New York...

Author: By Cyrus M. Sanai, | Title: A Writer in Writer's Clothing | 1/14/1987 | See Source »

...time with the idea of being ordained, but so far he has decided to remain a layman. Nonetheless, his career has almost always been in church affairs. After studying theology at London's Church Army College, he worked as a lay training adviser to the Anglican Bishop of Bristol. In 1968 he headed for Uganda to become an adviser to the local archbishop. Even then his life was infected with a dash of danger. In 1971 he and his wife Frances, who have three daughters and a son, were held at gunpoint for some hours during a mass expulsion...

Author: /time Magazine | Title: Terry Waite: An Extraordinary Envoy | 11/10/1986 | See Source »

Kennedy School administrator Richard T. Howe '69 is running for State Senate in his home district, the First Bristol, as the only challenger to 24-year incumbent John F. Parker (R-Taunton...

Author: By Martha A. Bridegam, | Title: K-School Administrator Faces Senate Veteran | 11/4/1986 | See Source »

Manufacturing over-the-counter capsules has been a fast-growing, profitable business (1985 sales: $1.5 billion), but the market is suddenly shrinking. Within the past five months, both Bristol-Meyers and Johnson & Johnson, the maker of Tylenol, have stopped selling any of their nonprescription drugs in capsule form. While most other manufacturers insist that they have no current intention of walking away from this market, consumers and producers across the U.S. are pondering the uncertain fate of the still popular product...

Author: /time Magazine | Title: The Great Capsule Controversy | 7/7/1986 | See Source »

Still, manufacturers are facing tough decisions. It will cost Johnson & Johnson $150 million to pull out of the capsule market, and Bristol-Meyers will lose $38 million. These days executives are voicing varying degrees of commitment to the controversial capsule. Said a spokesman for American Home Products: "We have no intention at this point in time of discontinuing our over-the-counter capsule business." At another time, he implies, things could change. Echoed a spokesman for Sterling Drug, maker of Panadol and Midol pain relievers: "We are still marketing the capsules. But it's a fluid situation. Any instance, such...

Author: /time Magazine | Title: The Great Capsule Controversy | 7/7/1986 | See Source »

Previous | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | Next